Camp4 Therapeutics Corporation (CAMP)
NASDAQ: CAMP · Real-Time Price · USD
3.800
-0.290 (-7.09%)
Nov 13, 2026, 4:00 PM EST - Market closed

Camp4 Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22
Revenue
5.323.50.650.35-
Revenue Growth
39.93%436.50%86.29%--
Gross Profit
-34.95-34.7-38.17-40.27-34.1
Operating Income
-52.76-52.06-53.09-51.88-45
Net Income
-121.1-80.4-51.79-49.29-44.19
Earnings Per Share
-1.95-2.65-11.04-124.79-141.51
EPS Growth
-----

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22
Cash & Investments
124.52109.5264.0438.3883.19
Total Debt
6.4528.6612.1812.4
Net Cash (Debt)
118.07107.5255.3826.270.8
Net Cash Growth
71.34%94.16%111.38%-63.00%-
Net Cash Per Share
1.903.5411.8166.33226.69

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22
Operating Cash Flow
-25.54-29.55-45.56-44.16-38.54
Capital Expenditures
-0.87-0.28-0.44-0.68-4.03
Free Cash Flow
-26.41-29.83-46-44.83-42.57
Free Cash Flow Growth
-----

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22
Operating Margin
-991.77%-1488.31%-8142.33%-14822.57%-
Pretax Margin
-2276.33%-2298.54%-7943.40%-14083.14%-
Profit Margin
-2276.34%-2298.54%-7943.40%-14083.14%-
FCF Margin
-496.39%-852.83%-7055.67%-12809.43%-

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22
PS Ratio
44.8290.92161.17--